世界のまれな病気の治療市場：市場規模・現状・予測

• 英文タイトル：Global Rare Disease Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7935 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、まれな病気の治療のグローバル市場について調査・分析したレポートで、種類別（オリジネーターの薬、ジェネリック医薬品）、用途別（病院薬局、専門薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・まれな病気の治療の世界市場規模 ・主要企業別市場シェア ・まれな病気の治療の世界市場規模：種類別（オリジネーターの薬、ジェネリック医薬品） ・まれな病気の治療の世界市場規模：用途別（病院薬局、専門薬局、小売薬局） ・まれな病気の治療のアメリカ市場規模（種類別、用途別） ・まれな病気の治療のヨーロッパ市場規模（種類別、用途別） ・まれな病気の治療の中国市場規模（種類別、用途別） ・まれな病気の治療の日本市場規模（種類別、用途別） ・まれな病気の治療の東南アジア市場規模（種類別、用途別） ・まれな病気の治療のインド市場規模（種類別、用途別） ・まれな病気の治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・まれな病気の治療の世界市場予測（2019年-2025年） ・まれな病気の治療の地域別市場予測（2019年-2025年） ...

A rare disease is any disease that affects a small percentage of the population.Most rare diseases are genetic and thus are present throughout the person’s entire life, even if symptoms do not immediately appear.
In 2018, the global Rare Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Disease Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
F. Hoffmann-La Roche
Celgene
AbbVie
Johnson & Johnson
Shire
Alexion
Novo Nordisk
Sanofi
Bayer
Amgen
Allergan
Eisai
Bristol-Myers Squibb
Merck
Vertex Pharmaceuticals
Baxter
BioMarin
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Originator Drugs
Generic Drugs

Market segment by Application, split into
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rare Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Rare Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rare Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Originator Drugs
1.4.3 Generic Drugs
1.5 Market by Application
1.5.1 Global Rare Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Specialty Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rare Disease Treatment Market Size
2.2 Rare Disease Treatment Growth Trends by Regions
2.2.1 Rare Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Rare Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rare Disease Treatment Market Size by Manufacturers
3.1.1 Global Rare Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Rare Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rare Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Rare Disease Treatment Key Players Head office and Area Served
3.3 Key Players Rare Disease Treatment Product/Solution/Service
3.4 Date of Enter into Rare Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rare Disease Treatment Market Size by Type (2014-2019)
4.2 Global Rare Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Rare Disease Treatment Market Size (2014-2019)
5.2 Rare Disease Treatment Key Players in United States
5.3 United States Rare Disease Treatment Market Size by Type
5.4 United States Rare Disease Treatment Market Size by Application

6 Europe
6.1 Europe Rare Disease Treatment Market Size (2014-2019)
6.2 Rare Disease Treatment Key Players in Europe
6.3 Europe Rare Disease Treatment Market Size by Type
6.4 Europe Rare Disease Treatment Market Size by Application

7 China
7.1 China Rare Disease Treatment Market Size (2014-2019)
7.2 Rare Disease Treatment Key Players in China
7.3 China Rare Disease Treatment Market Size by Type
7.4 China Rare Disease Treatment Market Size by Application

8 Japan
8.1 Japan Rare Disease Treatment Market Size (2014-2019)
8.2 Rare Disease Treatment Key Players in Japan
8.3 Japan Rare Disease Treatment Market Size by Type
8.4 Japan Rare Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rare Disease Treatment Market Size (2014-2019)
9.2 Rare Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Rare Disease Treatment Market Size by Type
9.4 Southeast Asia Rare Disease Treatment Market Size by Application

10 India
10.1 India Rare Disease Treatment Market Size (2014-2019)
10.2 Rare Disease Treatment Key Players in India
10.3 India Rare Disease Treatment Market Size by Type
10.4 India Rare Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Rare Disease Treatment Market Size (2014-2019)
11.2 Rare Disease Treatment Key Players in Central & South America
11.3 Central & South America Rare Disease Treatment Market Size by Type
11.4 Central & South America Rare Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rare Disease Treatment Introduction
12.1.4 Novartis Revenue in Rare Disease Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rare Disease Treatment Introduction
12.2.4 Pfizer Revenue in Rare Disease Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rare Disease Treatment Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Celgene
12.4.1 Celgene Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rare Disease Treatment Introduction
12.4.4 Celgene Revenue in Rare Disease Treatment Business (2014-2019)
12.4.5 Celgene Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rare Disease Treatment Introduction
12.5.4 AbbVie Revenue in Rare Disease Treatment Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rare Disease Treatment Introduction
12.6.4 Johnson & Johnson Revenue in Rare Disease Treatment Business (2014-2019)
12.6.5 Johnson & Johnson Recent Development
12.7 Shire
12.7.1 Shire Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rare Disease Treatment Introduction
12.7.4 Shire Revenue in Rare Disease Treatment Business (2014-2019)
12.7.5 Shire Recent Development
12.8 Alexion
12.8.1 Alexion Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rare Disease Treatment Introduction
12.8.4 Alexion Revenue in Rare Disease Treatment Business (2014-2019)
12.8.5 Alexion Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rare Disease Treatment Introduction
12.9.4 Novo Nordisk Revenue in Rare Disease Treatment Business (2014-2019)
12.9.5 Novo Nordisk Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rare Disease Treatment Introduction
12.10.4 Sanofi Revenue in Rare Disease Treatment Business (2014-2019)
12.10.5 Sanofi Recent Development
12.11 Bayer
12.12 Amgen
12.13 Allergan
12.14 Eisai
12.15 Bristol-Myers Squibb
12.16 Merck
12.17 Vertex Pharmaceuticals
12.18 Baxter
12.19 BioMarin
12.20 Teva Pharmaceutical Industries

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Rare Disease Treatment Key Market Segments
Table Key Players Rare Disease Treatment Covered
Table Global Rare Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rare Disease Treatment Market Size Market Share by Type 2014-2025
Figure Originator Drugs Figures
Table Key Players of Originator Drugs
Figure Generic Drugs Figures
Table Key Players of Generic Drugs
Table Global Rare Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Specialty Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Rare Disease Treatment Report Years Considered
Table Global Rare Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Rare Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rare Disease Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Rare Disease Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Rare Disease Treatment Market Share by Regions 2014-2019
Figure Global Rare Disease Treatment Market Share by Regions 2014-2019
Figure Global Rare Disease Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Rare Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rare Disease Treatment Market Share by Manufacturers (2014-2019)
Figure Global Rare Disease Treatment Market Share by Manufacturers in 2018
Table Global Rare Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rare Disease Treatment Product/Solution/Service
Table Date of Enter into Rare Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Rare Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Rare Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Rare Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Rare Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Rare Disease Treatment Revenue Market Share by Application in 2018
Figure United States Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Rare Disease Treatment Market Share (2018-2019)
Table United States Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Rare Disease Treatment Market Share by Type (2014-2019)
Table United States Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Rare Disease Treatment Market Share by Application (2014-2019)
Figure Europe Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Rare Disease Treatment Market Share (2018-2019)
Table Europe Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Rare Disease Treatment Market Share by Type (2014-2019)
Table Europe Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Rare Disease Treatment Market Share by Application (2014-2019)
Figure China Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Rare Disease Treatment Market Share (2018-2019)
Table China Rare Disease Treatment Market Size by Type (2014-20189) (Million US$)
Table China Rare Disease Treatment Market Share by Type (2014-2019)
Table China Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table China Rare Disease Treatment Market Share by Application (2014-2019)
Figure Japan Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Rare Disease Treatment Market Share (2018-2019)
Table Japan Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Rare Disease Treatment Market Share by Type (2014-2019)
Table Japan Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Rare Disease Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rare Disease Treatment Market Share (2018-2019)
Table Southeast Asia Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rare Disease Treatment Market Share by Type (2014-2019)
Table Southeast Asia Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rare Disease Treatment Market Share by Application (2014-2019)
Figure India Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Rare Disease Treatment Market Share (2018-2019)
Table India Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table India Rare Disease Treatment Market Share by Type (2014-2019)
Table India Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table India Rare Disease Treatment Market Share by Application (2014-2019)
Figure Central & South America Rare Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rare Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rare Disease Treatment Market Share (2018-2019)
Table Central & South America Rare Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rare Disease Treatment Market Share by Type (2014-2019)
Table Central & South America Rare Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rare Disease Treatment Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Rare Disease Treatment Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Celgene Company Details
Table Celgene Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Celgene Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Shire Company Details
Table Shire Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Shire Recent Development
Table Alexion Company Details
Table Alexion Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Alexion Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Alexion Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Rare Disease Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Rare Disease Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Bayer Company Details
Table Amgen Company Details
Table Allergan Company Details
Table Eisai Company Details
Table Bristol-Myers Squibb Company Details
Table Merck Company Details
Table Vertex Pharmaceuticals Company Details
Table Baxter Company Details
Table BioMarin Company Details
Table Teva Pharmaceutical Industries Company Details
Table Global Rare Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Rare Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Rare Disease Treatment Market Size Share by Regions in 2025
Figure United States Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rare Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Rare Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Rare Disease Treatment Market Size by Product (2019-2025)
Figure Global Rare Disease Treatment Market Size by Product in 2025
Table Global Rare Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Rare Disease Treatment Market Size by Application (2019-2025)
Figure Global Rare Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---